PLYMOUTH
MEETING, Pa., June 4, 2024
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company
focused on developing and commercializing DNA medicines
to help treat and protect people from HPV-associated diseases,
cancer and infectious diseases, today announced that INOVIO's
President and CEO, Dr. Jacqueline
Shea, and Chief Medical Officer, Dr. Michael Sumner will participate in a virtual
fireside chat hosted by Sudan Loganathan, Ph.D., Managing Director
and equity research analyst at Stephens, Inc.
The fireside chat will take place on Tuesday, June 11, 2024, at 11:00am ET. This event is only available to
institutional clients of Stephens. Please reach out to your
Stephens contact for event details.
About INOVIO
INOVIO is a biotechnology company focused
on developing and commercializing DNA medicines to help treat and
protect people from HPV-related diseases, cancer, and infectious
diseases. INOVIO's technology optimizes the design and delivery of
innovative DNA medicines that teach the body to manufacture its own
disease-fighting tools. For more information, visit
www.inovio.com.
Contacts
Media: Jennie
Willson, (267) 429-8567, jennie.willson@inovio.com
Investors: Thomas Hong, (267)
440-4298, thomas.hong@inovio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-virtual-fireside-chat-hosted-by-stephens-inc-302162633.html
SOURCE INOVIO Pharmaceuticals, Inc.